Vimobin Labs: Financial Breakdown
Decoding financial health metrics of Vimobin Labs
Total Revenue₹18.5 Lakh46%Prev. FY
Total Expenses₹28.9 Lakh70%Prev. FY
Profit After Tax₹-10.3 Lakh-140%Prev. FY
Total Assets₹4.0 Lakh101%Prev. FY
Net Profit Margin-55.8%-64%Prev. FY
FAQs on Financials of Vimobin Labs
No. In FY25, Vimobin Labs reported a net loss of ₹10.3 Lakh, so it was not profitable.
Vimobin Labs's revenue grew 46.2% year-on-year, from ₹12.7 Lakh in FY24 to ₹18.5 Lakh in FY25.
Vimobin Labs's estimated EBITDA for FY25 was ₹-10.2 Lakh, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY25, Vimobin Labs posted revenue of ₹18.5 Lakh (up 46.2% YoY) and a net loss of ₹10.3 Lakh. Explore the full financials of Vimobin Labs here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links